Yednock Ted's Insider Trades & SAST Disclosures
Yednock Ted's most recent trade in Annexon Inc was a trade of 272,575 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 27, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Yednock Ted.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Annexon Inc | Ted Yednock | EVP & CHIEF INNOVATION OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 272,575 | 272,575 | - | - | Stock Option (Right to Buy) | |
| Annexon Inc | Ted Yednock | EVP & CHIEF INNOVATION OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 44,963 | 106,200 | - | 0 | Common Stock | |
| Annexon Inc | Ted Yednock | EVP & CHIEF INNOVATION OFFICER | Sale of securities on an exchange or to another person at price $ 2.91 per share. | 18 Feb 2025 | 8,345 | 61,237 | - | 2.9 | 24,284 | Common Stock |
| Annexon Inc | Ted Yednock | EVP & CHIEF INNOVATION OFFICER | Sale of securities on an exchange or to another person at price $ 2.99 per share. | 13 Feb 2025 | 1,783 | 69,582 | - | 3.0 | 5,331 | Common Stock |
| Annexon Inc | Ted Yednock | EVP & CHIEF INNOVATION OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.85 per share. | 15 Oct 2024 | 5,408 | 76,773 | - | 1.9 | 10,005 | Common Stock |
| Annexon Inc | Ted Yednock | EVP & CHIEF INNOVATION OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2024 | 5,408 | 30,646 | - | - | Stock Option (Right to Buy) | |
| Annexon Inc | Ted Yednock | EVP & CHIEF INNOVATION OFFICER | Sale of securities on an exchange or to another person at price $ 7.41 per share. | 15 Oct 2024 | 5,408 | 71,365 | - | 7.4 | 40,073 | Common Stock |
| Annexon Inc | Ted Yednock | EVP & CHIEF INNOVATION OFFICER | Sale of securities on an exchange or to another person at price $ 7.10 per share. | 19 Sep 2024 | 4,500 | 0 | - | 7.1 | 31,950 | Common Stock |
| Annexon Inc | Ted Yednock | EVP & CHIEF INNOVATION OFFICER | Sale of securities on an exchange or to another person at price $ 6.16 per share. | 12 Sep 2024 | 5,500 | 4,500 | - | 6.2 | 33,880 | Common Stock |
| Annexon Inc | Ted Yednock | EVP & CHIEF INNOVATION OFFICER | Sale of securities on an exchange or to another person at price $ 5.64 per share. | 05 Sep 2024 | 5,500 | 10,000 | - | 5.6 | 31,020 | Common Stock |
| Annexon Inc | Ted Yednock | EVP & CHIEF INNOVATION OFFICER | Sale of securities on an exchange or to another person at price $ 5.95 per share. | 29 Aug 2024 | 5,500 | 15,500 | - | 6.0 | 32,725 | Common Stock |
| Annexon Inc | Ted Yednock | EVP & CHIEF INNOVATION OFFICER | Sale of securities on an exchange or to another person at price $ 6.02 per share. | 15 Jul 2024 | 1,106 | 71,365 | - | 6.0 | 6,658 | Common Stock |
| Annexon Inc | Ted Yednock | EVP & CHIEF INNOVATION OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 160,000 | 160,000 | - | - | Stock Option (Right to Buy) | |
| Annexon Inc | Ted Yednock | EVP & CHIEF INNOVATION OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 39,000 | 75,075 | - | 0 | Common Stock | |
| Annexon Inc | Ted Yednock | EVP & CHIEF INNOVATION OFFICER | Sale of securities on an exchange or to another person at price $ 5.51 per share. | 16 Feb 2024 | 2,604 | 72,471 | - | 5.5 | 14,348 | Common Stock |
| Annexon Inc | Ted Yednock | EVP & CHIEF INNOVATION OFFICER | Sale of securities on an exchange or to another person at price $ 5.54 per share. | 12 Feb 2024 | 1,810 | 36,075 | - | 5.5 | 10,027 | Common Stock |
| Annexon Inc | Ted Yednock | EVP & Chief Innovation Officer | Sale of securities on an exchange or to another person at price $ 4.52 per share. | 27 Dec 2023 | 21,000 | 0 | - | 4.5 | 94,966 | Common Stock |
| Annexon Inc | Ted Yednock | EVP & Chief Innovation Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Dec 2023 | 10,615 | 0 | - | - | Stock Option (Right to Buy) | |
| Annexon Inc | Yednock Ted | EVP & Chief Innovation Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.41 per share. | 27 Dec 2023 | 10,615 | 10,615 | - | 1.4 | 14,963 | Common Stock |
| Annexon Inc | Ted Yednock | EVP & Chief Innovation Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Dec 2023 | 10,385 | 36,000 | - | - | Stock Option (Right to Buy) | |
| Annexon Inc | Ted Yednock | EVP & Chief Innovation Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.85 per share. | 27 Dec 2023 | 10,385 | 21,000 | - | 1.9 | 19,213 | Common Stock |
| Annexon Inc | Yednock Ted | EVP & Chief Innovation Officer | Sale of securities on an exchange or to another person at price $ 4.52 per share. | 11 Jul 2023 | 21,000 | 37,885 | - | 4.5 | 94,966 | Common Stock |
| Annexon Inc | Ted Yednock | EVP & Chief Innovation Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.41 per share. | 11 Jul 2023 | 10,615 | 48,500 | - | 1.4 | 14,963 | Common Stock |
| Annexon Inc | Ted Yednock | EVP & Chief Innovation Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.85 per share. | 11 Jul 2023 | 10,385 | 58,885 | - | 1.9 | 19,213 | Common Stock |
| Annexon Inc | Yednock Ted | EVP & Chief Innovation Officer | Sale of securities on an exchange or to another person at price $ 3.84 per share. | 11 Jul 2023 | 1,057 | 37,885 | - | 3.8 | 4,055 | Common Stock |
| Annexon Inc | Ted Yednock | EVP & Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 13 Sep 2021 | 16,190 | 0 | - | 20.0 | 323,860 | Common Stock |
| Annexon Inc | Ted Yednock | EVP & Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.41 per share. | 13 Sep 2021 | 15,000 | 15,000 | - | 1.4 | 21,144 | Common Stock |
| Annexon Inc | Ted Yednock | EVP & Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Sep 2021 | 15,000 | 10,615 | - | - | Stock Option (Right to Buy) | |
| Annexon Inc | Ted Yednock | EVP & Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.11 per share. | 13 Sep 2021 | 1,190 | 16,190 | - | 5.1 | 6,081 | Common Stock |
| Annexon Inc | Ted Yednock | EVP & Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Sep 2021 | 1,190 | 67,939 | - | - | Stock Option (Right to Buy) | |
| Annexon Inc | Ted Yednock | EVP & Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2021 | 15,000 | 25,615 | - | - | Stock Option (Right to Buy) | |
| Annexon Inc | Ted Yednock | EVP & Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.41 per share. | 03 Jun 2021 | 15,000 | 15,000 | - | 1.4 | 21,144 | Common Stock |
| Annexon Inc | Ted Yednock | EVP & Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 21.45 per share. | 03 Jun 2021 | 12,816 | 2,184 | - | 21.4 | 274,884 | Common Stock |
| Annexon Inc | Ted Yednock | EVP & Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 21.72 per share. | 03 Jun 2021 | 2,184 | 0 | - | 21.7 | 47,441 | Common Stock |
| Annexon Inc | Ted Yednock | EVP & Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Mar 2021 | 15,000 | 40,615 | - | - | Stock Option (Right to Buy) | |
| Annexon Inc | Ted Yednock | EVP & Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.41 per share. | 25 Mar 2021 | 15,000 | 15,000 | - | 1.4 | 21,144 | Common Stock |
| Annexon Inc | Ted Yednock | EVP & Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 28.54 per share. | 25 Mar 2021 | 10,258 | 5,917 | - | 28.5 | 292,755 | Common Stock |
| Annexon Inc | Ted Yednock | EVP & Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 29.21 per share. | 25 Mar 2021 | 5,680 | 237 | - | 29.2 | 165,914 | Common Stock |
| Annexon Inc | Ted Yednock | EVP & Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.11 per share. | 25 Mar 2021 | 1,175 | 16,175 | - | 5.1 | 6,004 | Common Stock |
| Annexon Inc | Ted Yednock | EVP & Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Mar 2021 | 1,175 | 69,129 | - | - | Stock Option (Right to Buy) | |
| Annexon Inc | Ted Yednock | EVP & Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 29.96 per share. | 25 Mar 2021 | 237 | 0 | - | 30.0 | 7,101 | Common Stock |
| Annexon Inc | Ted Yednock | EVP & Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 115,000 | 115,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges